{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T09:09:01.390102+00:00","published_at":"2026-10-17T04:46:55.096783+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:charles-frantzreb","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Charles Frantzreb","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:diem-nguyen","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Diem Nguyen","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:gavin-corcoran","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Gavin Corcoran","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:jayson-rieger","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Jayson Rieger","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:lawrence-eichenfield","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Lawrence Eichenfield","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:mark-prygocki","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Mark Prygocki","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:paul-b-manning","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Paul B. Manning","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"seat_on","from_id":"alpha:person:sean-stalfort","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Sean Stalfort","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:audit","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Audit","to_label":"Verrica Pharmaceuticals Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:chairs:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17:committee:verrica-pharmaceuticals-inc:audit","relationship_type":"chairs","from_id":"alpha:person:mark-prygocki","to_id":"alpha:committee:verrica-pharmaceuticals-inc:audit","from_label":"Mark Prygocki","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17:committee:verrica-pharmaceuticals-inc:audit","relationship_type":"member_of","from_id":"alpha:person:diem-nguyen","to_id":"alpha:committee:verrica-pharmaceuticals-inc:audit","from_label":"Diem Nguyen","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Audit · Chair; Compensation; Nominating and Governance","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:mark-prygocki","to_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance","from_label":"Mark Prygocki","to_label":"Audit · Chair; Compensation; Nominating and Governance","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-chair","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Audit; Compensation · Chair","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6:committee:verrica-pharmaceuticals-inc:audit-compensation-chair","relationship_type":"member_of","from_id":"alpha:person:diem-nguyen","to_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-chair","from_label":"Diem Nguyen","to_label":"Audit; Compensation · Chair","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Audit; Compensation; Nominating and Governance · Chair","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","relationship_type":"member_of","from_id":"alpha:person:lawrence-eichenfield","to_id":"alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","from_label":"Lawrence Eichenfield","to_label":"Audit; Compensation; Nominating and Governance · Chair","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:compensation","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Compensation","to_label":"Verrica Pharmaceuticals Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:chairs:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21:committee:verrica-pharmaceuticals-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:diem-nguyen","to_id":"alpha:committee:verrica-pharmaceuticals-inc:compensation","from_label":"Diem Nguyen","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21:committee:verrica-pharmaceuticals-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:lawrence-eichenfield","to_id":"alpha:committee:verrica-pharmaceuticals-inc:compensation","from_label":"Lawrence Eichenfield","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"committee_of","from_id":"alpha:committee:verrica-pharmaceuticals-inc:nominating-and-governance","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Nominating and Governance","to_label":"Verrica Pharmaceuticals Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:chairs:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25:committee:verrica-pharmaceuticals-inc:nominating-and-governance","relationship_type":"chairs","from_id":"alpha:person:lawrence-eichenfield","to_id":"alpha:committee:verrica-pharmaceuticals-inc:nominating-and-governance","from_label":"Lawrence Eichenfield","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:member_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25:committee:verrica-pharmaceuticals-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:mark-prygocki","to_id":"alpha:committee:verrica-pharmaceuticals-inc:nominating-and-governance","from_label":"Mark Prygocki","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25","evidence_ids":["alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"executive_of","from_id":"alpha:person:david-zawitz","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"David Zawitz","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2026-04-20","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"executive_of","from_id":"alpha:person:jayson-rieger","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Jayson Rieger","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2026-04-20","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"executive_of","from_id":"alpha:person:john-j-kirby","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"John J. Kirby","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2026-04-20","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","relationship_type":"executive_of","from_id":"alpha:person:noah-rosenberg","to_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","from_label":"Noah Rosenberg","to_label":"Verrica Pharmaceuticals Inc.","valid_from":"2026-04-20","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c"]}]},"claims":[{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-frantzreb","object_label":"Charles Frantzreb","object_source_name_forms":[],"value":"Charles Frantzreb: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-frantzreb","name":"Charles Frantzreb"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diem-nguyen","object_label":"Diem Nguyen","object_source_name_forms":[],"value":"Diem Nguyen: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diem-nguyen","name":"Diem Nguyen"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gavin-corcoran","object_label":"Gavin Corcoran","object_source_name_forms":[],"value":"Gavin Corcoran: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gavin-corcoran","name":"Gavin Corcoran"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jayson-rieger","object_label":"Jayson Rieger","object_source_name_forms":[],"value":"Jayson Rieger: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jayson-rieger","name":"Jayson Rieger"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lawrence-eichenfield","object_label":"Lawrence Eichenfield","object_source_name_forms":[],"value":"Lawrence Eichenfield: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lawrence-eichenfield","name":"Lawrence Eichenfield"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mark-prygocki","object_label":"Mark Prygocki","object_source_name_forms":[],"value":"Mark Prygocki: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mark-prygocki","name":"Mark Prygocki"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-b-manning","object_label":"Paul B. Manning","object_source_name_forms":[],"value":"Paul B. Manning: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-b-manning","name":"Paul B. Manning"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:sean-stalfort","object_label":"Sean Stalfort","object_source_name_forms":[],"value":"Sean Stalfort: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:sean-stalfort","name":"Sean Stalfort"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:david-zawitz","object_label":"David Zawitz","object_source_name_forms":[],"value":"David Zawitz: Chief Operating Officer, Chief Legal Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:david-zawitz","name":"David Zawitz"},"title":"Chief Operating Officer, Chief Legal Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.37821+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jayson-rieger","object_label":"Jayson Rieger","object_source_name_forms":[],"value":"Jayson Rieger: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jayson-rieger","name":"Jayson Rieger"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.440001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-j-kirby","object_label":"John J. Kirby","object_source_name_forms":[],"value":"John J. Kirby: interim Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-j-kirby","name":"John J. Kirby"},"title":"interim Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.912524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:noah-rosenberg","object_label":"Noah Rosenberg","object_source_name_forms":[],"value":"Noah Rosenberg: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:noah-rosenberg","name":"Noah Rosenberg"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-20","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-20","valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.839874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-20T00:00:00+00:00","effective_from":"2026-04-20","effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Mark Prygocki; Members Mark Prygocki (Chair); Diem Nguyen; Lawrence Eichenfield","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Mark Prygocki","members":[{"display_name":"Mark Prygocki","person_slug":"mark-prygocki","is_chair":true},{"display_name":"Diem Nguyen","person_slug":"diem-nguyen","is_chair":false},{"display_name":"Lawrence Eichenfield","person_slug":"lawrence-eichenfield","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Diem Nguyen; Members Diem Nguyen (Chair); Lawrence Eichenfield; Mark Prygocki","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Diem Nguyen","members":[{"display_name":"Diem Nguyen","person_slug":"diem-nguyen","is_chair":true},{"display_name":"Lawrence Eichenfield","person_slug":"lawrence-eichenfield","is_chair":false},{"display_name":"Mark Prygocki","person_slug":"mark-prygocki","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25","subject_id":"alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Lawrence Eichenfield; Members Lawrence Eichenfield (Chair); Mark Prygocki","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Lawrence Eichenfield","members":[{"display_name":"Lawrence Eichenfield","person_slug":"lawrence-eichenfield","is_chair":true},{"display_name":"Mark Prygocki","person_slug":"mark-prygocki","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:55.096783+00:00","sources":[{"id":"alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20","retrieved_at":"2026-04-25T00:18:01.546+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.37821+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.440001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:18.912524+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"VRCA DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":"2026-04-20T00:00:00+00:00","retrieved_at":"2026-05-16T09:58:19.839874+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.841,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.6},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":12,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:55.096783+00:00","observed_at":"2026-10-17T04:46:55.096783+00:00","reviewed_at":"2026-10-17T04:46:55.096783+00:00","verified_at":"2026-10-17T04:46:55.096783+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/verrica-pharmaceuticals-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}